Erbb2 inhibitors (Academia Sinica)

N/A

Report date: 2025/03/20 15:44:11
NME

Base Information

Drug NameErbb2 inhibitors (Academia Sinica)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsBeta amyloid A4 protein inhibitors
TargetsReceptor protein-tyrosine kinase erbB-2Beta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcademia Sinica
China Registration ClassN/A

Develop Information

Active CompaniesAcademia Sinica
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A